• Log in
  • Home
  • EABE
  • My Articles
  • Submit an Article
  • Online Volumes
  • Older issues
  • Contact us

The role of magnesium in heart failure: a systematic review

November 3, 2019 · Issue 3,Volume 11

Purpose: The detection of the association of serum magnesium on mortality and morbidity in Heart Failure patients.

Methods: The selection of the studies was based on searching in the databases, Pubmed and Scopus. The assessment of the quality of the selected studies was accomplished according to validated quality criteria in prognostic studies (QUIPS tool).

Results: Eight studies were considered appropriate for participating in the systematic review, which include 8651 Heart Failure patients with low LVEF (left ventricular ejection fraction). In half of studies, hypomagnesemia is considered to be independent prognostic factor for cardiovascular mortality, including sudden death. Only in one study did magnesium levels >2.4 mg/dl constitute independent prognostic factor for all-cause mortality, whilst there was no statistical association between serum magnesium and morbidity outcomes in Heart Failure patients.

Conclusion: Heart failure patients who develop hypomagnesemia at heightened risk of increased cardiovascular mortality, including sudden death.

Keywords:

 Heart failure, Magnesium, Mortality, Morbidity

Celiac disease and cardiovascular disease

November 3, 2019 · Issue 3,Volume 11

Celiac disease is a chronic inflammatory enteropathy, caused by the consumption of foodstuffs containing gluten. The aim of this review is to explore the data concerning the association between celiac disease, atherosclerosis and cardiovascular diseases, and the role of inflammation as a causative factor.

Keywords

celiac disease, atherosclerosis, cardiovascular disease

The role of PCSK9 in atherosclerosis: a new age in dyslipidemia management

November 3, 2019 · Issue 3,Volume 11

PCSK9 is a protein with proven deleterious effects on lipid metabolism. PCSK9 facilitates the degradation of the LDL receptors on the surface of hepatocytes. As a result, LDL concentrations in the serum increase. Statin therapy stimulates a positive feedback circle which causes PCSK9 levels to increase, attenuating statin’s efficiency. PCSK9 inhibitors have proven themselves in several clinical trials as safe drugs that cause significant improvements in lipid profiles. The purpose of this review is to fully delineate the link between PCSK9 and atherosclerosis, as well as the future of PCSK9 inhibition.

Spontaneous coronary artery dissection (SCAD) and acute coronary syndrome. A review of nine cases.

November 3, 2019 · Issue 3,Volume 11

Spontaneous coronary artery dissection (SCAD) is considered a non-traumatic, non-iatrogenic rupture of the coronary artery wall with a consequential formation of a false lumen and an intramural hematoma (IMH), capable under certain circumstances of compressing the true lumen causing acute coronary syndrome. We report our recent experience in the field, by presenting 9 different cases of SCAD, first admitted with an initial diagnosis of non-ST segment elevation myocardial infarction (NSTEMI). We additionally provide a brief review of the literature.

About Atherologia

ΑΘΗΡΟλογία (Athirologia) is the journal of the Atherosclerosis Society of Northern Greece. issues are published three times per year.

Editorial Team

Editor-in-Chief
Papadopoulos Christodoulos, MD, PhD
Thessaloniki, Greece

Deputy Editor
Bakogiannis Constantinos, MD, PhD
Thessaloniki, Greece

Executive Managing Editor
Tsarouchas Anastasios-Stylianos, MD
Thessaloniki, Greece

Editorial Director
Mouselimis Dimitrios, MD
Thessaloniki, Greece

Associate Editors

Skoutas Dimitrios, MD, PhD
Thessaloniki, Greece

Efthimiadis Ioannis, MD, PhD
Thessaloniki, Greece

Doumas Michael, MD, PhD
Thessaloniki, Greece

Giannakoulas George, MD, PhD
Thessaloniki, Greece

Zioutas Dimitrios, MD, PhD
Thessaloniki, Greece

Karkos Christos, MD, PhD,
Thessaloniki, Greece

Papadopoulou-Lempeglou Kiriaki, MD, PhD
Thessaloniki, Greece

  • About Annotum